← Browse by Condition
Medical Condition
nonsmall cell lung cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05283330 Phase 1
Recruiting
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Enrollment
48 pts
Location
United States
Sponsor
Orano Med LLC
NCT06147570 Phase 2
Recruiting
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Enrollment
62 pts
Location
China
Sponsor
Jiangsu Hansoh Pharmaceutical ...